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Abstract
Background: In situ hybridisation gene expression information helps biologists identify where a gene is expressed.
However, the databases that republish the experimental information online are often both incomplete and
inconsistent. Non-monotonic reasoning can help resolve such difficulties - one such form of reasoning is
computational argumentation. Essentially this involves asking a computer to debate (i.e. reason about) the validity
of a particular statement. Arguments are produced for both sides - the statement is true and, the statement is false
- then the most powerful argument is used. In this work the computer is asked to debate whether or not a gene
is expressed in a particular mouse anatomical structure. The information generated during the debate can be
passed to the biological end-user, enabling their own decision-making process.
Results: This paper examines the evolution of a system, Argudas, which tests using computational argumentation
in an in situ gene hybridisation gene expression use case. Argudas reasons using information extracted from
several different online resources that publish gene expression information for the mouse. The development and
evaluation of two prototypes is discussed. Throughout a number of issues shall be raised including the
appropriateness of computational argumentation in biology and the challenges faced when integrating apparently
similar online biological databases.
Conclusions: From the work described in this paper it is clear that for argumentation to be effective in the
biological domain the argumentation community need to develop further the tools and resources they provide.
Additionally, the biological community must tackle the incongruity between overlapping and adjacent resources,
thus facilitating the integration and modelling of biological information. Finally, this work highlights both the
importance of, and difficulty in creating, a good model of the domain.
Background
In order to gain an insight into the appropriateness of
argumentation for the wider biological world this work
concentrates on employing argumentation within the
field of in situ gene expression. This section contains a
short introduction to argumentation, followed by a
description of the relevant previous work. Initially the
focus is on in situ gene expression information and the
areas in which argumentation may be fruitfully applied.
Gene expression information, inconsistency, and
incompleteness
Gene expression information describes whether or not a
gene is expressed (active) in a location. Broadly speaking
there are two types of gene expression information: one
that concentrates on where the gene is expressed, and a
second whose primary concern is the strength of expres-
sion. Throughout, this work focuses on the former cate-
gory, in particular a technology called in situ
hybridisation gene expression.
Information on gene expression is often given in rela-
tion to a structure - or it may be given for a point in
3D space - in a particular model organism. Here the
model organism of interest is the mouse. This organism
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is studied from conception until adulthood. The time
window is split into twenty-eight Theiler Stages. Each
stage has its own anatomy, and corresponding anatomy
ontology called EMAP [1]. The first twenty-six stages
cover the developmental mouse: the mouse from con-
ception until birth. Stage 27 is the new born mouse, and
28 the adult.
The result of an in situ experiment is represented as
an image displaying a slice (2D cross section) of a
mouse (from a particular Theiler Stage) in which some
subsections of the mouse are highly coloured. Areas of
colour indicate that the gene is expressed in that loca-
tion. In addition to showing where the gene is
expressed, the image provides some indication of the
strength (or level) of expression. The more intense the
colour, the stronger the expression.
Result images are analysed manually. A human expert
determines in which structures the gene is expressed,
and at what level of expression. As strength information
is not the main focus of the experiment, its description
is often vague using loose natural language terms such
as strong, moderate, weak or present. For example, the
gene bmp4 is strongly expressed in the future brain at
Theiler Stage 15.
Once an in situ gene expression experiment is com-
pleted the experiment may be published in a traditional
journal. Regardless of whether or not this is true, the
experiment usually will be published by one (or more)
online resources. Two of the main resources in the cur-
rent domain of interest are EMAGE [2] and GXD [3] -
both use the EMAP anatomy ontology. These online
databases publish so-called annotations that contain par-
ticular types of information: provenance, details of the
technique used, analysis of the result, and perhaps some
indication of how reliable the resource believes the
experiment to be. It is possible to supply information
directly to the resources, and thus omit the traditional
journal publication. Often such a route is favoured by
large-scale projects that conduct a great number of
experiments.
Although EMAGE and GXD are substantial resources
they cannot be considered complete [4]. There is a
range of reasons for this phenomenon including: some
large scale projects publish their own results in a pro-
prietary database, some experiments are deemed of
insufficient quality by the resource curators, and others
simply ‘slip under the radar’. Consequently, in order to
build as complete a picture of the domain as possible, it
is necessary to consult multiple resources.
In addition to being incomplete, online biological
resources are often inconsistent [4]. In terms of gene
expression, this means that the same resource publishes
one annotation suggesting the gene is expressed in a
particular structure, and a second annotation suggesting
it is not. As biologists treat absent and expressed as
mutually exclusive, this implies an inconsistency. Due to
the complexity of the underlying experiments there are
a number of possible reasons for the different results,
including: differences in the interpretation of results,
unrecognised differences in the experiments, and human
error (by either the research team or the resource’s
curators). As discussed previously, it is necessary to use
synchronously multiple resources, but doing so raises
the prospect of inconsistency between those resources,
in addition to the inconsistency inside each resource.
Although there are many different methods to tackle
the issues described, the use of argumentation [5] is
considered in this work.
Argumentation
Argumentation [5] is a multidisciplinary field that stu-
dies arguments and arguing.
An argument is a reason to believe something is true.
This may be a formal proof, or a piece of natural lan-
guage: for example, a reason to carry an umbrella. The
crucial attribute of an argument is its defeasibility: an
argument may provide a reason to believe something is
true, but it does not prove it is definitely true.
Defeasibility is important because arguments can be in
conflict: one argument may suggest a conclusion is true
whilst a second argument intimates that the same con-
clusion is false. Often it is desirable to make a decision
about the validity of a conclusion. As the evidence and
corresponding arguments change over time, it may be
necessary to revise that decision. Defeasibility allows this
to happen.
Arguing (commonly called argumentation) is the pro-
cess of using arguments to justify a point of view. This
process may take place between multiple agents (human
or software) inside a debate, or it may be carried out by
a single agent: e.g. a political speech justifying the gov-
ernment’s decision to increase taxes.
The subdomain of computational argumentation
involves the use of computers for constructing and
using arguments. There is a wide range of domains in
which argumentation has been applied including: Artifi-
cial Intelligence & Law [6], ontology matching [7], medi-
cal decision support systems [8], and agent
communication [9].
Argumentation in relation to biology is surprisingly
rare. Jefferys et al. [10] use argumentation to analyse the
output of a protein prediction tool. However, most work
involves pedagogical efforts to improve the construction
of natural language scientific arguments by students, e.g.
[11].
Although argumentation is rare in biology, it is com-
mon within the medical world and is employed in a
wide range of decision support systems, for example [8].
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Additionally, argumentation can be used to persuade
patients to change their behaviour [12], and generate
pamphlets to explain complex issues to patients [13].
Although clear differences exist between medicine and
biology, there are many parallels. If argumentation has
been shown to work well in medicine, it should be rela-
tively successful in similar domains, e.g. biology.
Arguing over gene expression information
Initial attempts to tackle the twin problems of inconsis-
tency and incompleteness are documented in length in
previous work [14-16]; a brief reprise is given here.
McLeod et al. [14] describe an earlier system designed
to tackle the above problems. In effect, this system allows
a user to enquire if a gene is expressed in a particular ana-
tomical structure from an individual Theiler Stage. Doing
so causes the system to generate a number of arguments,
evaluate those arguments, and present the results (argu-
ment(s) and associated evaluation) to the user.
For the arguments to be meaningful, they have to be
based on expert knowledge - the expert employed for
this task was the senior editor of EMAGE. Expert
knowledge is captured in a series of natural language
inference rules, so-called argumentation schemes [17].
Essentially, these schemes provide a natural language if-
then (modus ponens) rule and an associated series of
questions that can be asked to ensure the rule’s applica-
tion is suitable in the current context. Additionally the
expert assigns a degree of confidence to each scheme.
The natural language schemes are converted into a
logical form using the method described by Verheij [18].
The logic in question is a PROLOG-like logic employed
by the ASPIC argumentation engine [8]. This tool pro-
vides a means to generate arguments, and conduct a vir-
tual debate between two agents in order to determine
which argument is strongest. Arguments are created by
the ASPIC argumentation engine using the rules, and
biological facts (information pulled dynamically at run-
time from EMAGE and GXD).
The rules inherit the confidence values of their
schemes, and likewise the arguments take the confidence
values from their rules. When two arguments are in con-
flict, the engine compares the confidence values, and
declares the argument with the higher value to be valid.
In McLeod et al. [14] the arguments are converted
back into natural language and presented to the user,
the presentation mechanism experts deemed most suita-
ble. Figure 1 part A shows a screen shot of the results
page: two arguments are displayed using one of ASPIC’s
in-built presentation mechanisms. Both arguments are
undefeated, which means the system believes them to be
true. Unfortunately, the default presentation style uses a
mixture of natural language and logic rendering it
unsuitable for use by the expected user group.
Subsequent work concentrated on the development,
and evaluation of an improved interface (see Figure 1
part B for the updated results page). This time the argu-
ments are presented entirely in natural language, and
preceded by an image that summarises the argumenta-
tion, which is below a single line conclusion (the gene is
expressed).
Sutherland et al. [16] discuss the inclusion of this
work in a semantic web browser for the life sciences.
Full details of the evaluation can be found in Ferguson
et al. [19]; though, McLeod et al. [15] publish the key
findings. In particular, the following issues are
prominent:
subjectivity - this affects the final conclusion (gene is/
is not expressed), the schemes, and their associated
degrees of belief;
breadth of resources - there is a need to include
other gene expression resources for the developmental
mouse, preferably featuring different techniques for
measuring gene expression.
Results and discussion
In 2009 work began to generate a real world tool to
help tackle the issues of inconsistency and incomplete-
ness in relation to in situ gene expression data for the
developmental mouse - this work is undertaken as the
Argudas project. Argudas is an evolution of the work
described previously, and in [14-16]. In the former work
two prototypes were developed, see Figure 1. During
Argudas, the system has been refined further through
the development of two additional implementations;
each with a similar, yet distinct, user interface.
This section will explore the knowledge gained from
the previous work, and the ways in which Argudas is
informed by those examples. The discussion starts with
an examination of the issue of subjectivity, then pro-
gresses to investigate the breadth of the resources
included in Argudas, and concludes with a review of the
issues highlighted by the first Argudas prototype.
Tackling subjectivity
One of the problems with the previous implementations
is the notion of subjectivity. During the evaluation it was
clear that each subject had their own approach to inter-
preting the information contained within EMAGE and
GXD. Accordingly, users disagreed with the system in
three key areas: the argumentation schemes, the confi-
dence values assigned to those schemes, and the final
conclusion the system presented. Each area of conflict
will now be addressed in turn.
Conclusions
At the top of a results page, e.g. Figure 1 part B, the
second prototype presents a conclusion as to whether or
not the gene is expressed, e.g. “The arguments appear to
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suggest the gene is expressed”. Each time a conclusion is
presented some users agree with it, yet others disagree.
A plausible reason for this is discussed by Jeffreys et al.
[10]:
Different researchers interpret data in different ways,
and even the same researcher may make inconsistent
interpretations, adding an unreliable and non-uni-
form element to data processing.
Figure 1 Initial prototype graphical user interfaces. A: The first prototype, results page - two true (undefeated) arguments are displayed
using the argumentation engine’s default presentation style. B: The second prototype, results page - a visual summary of the argumentation
appears above a list of natural language arguments.
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The phenomenon of subjectivity is explored, in rela-
tion to argumentation, in the philosophical writings of
Perelman and Olbrechts-Tyteca [20]. Perelman and
Olbrechts-Tyteca introduce the notion of an audience to
capture the idea that each person has their own reason-
ing process, and thus each member of an audience will
judge the same argument differently. This means that
there is little point in the system trying to decide
whether or not the gene is expressed. Instead the system
must generate arguments for and against the gene being
expressed, and allow the user to evaluate these argu-
ments in order to reach their own decision. In effect,
the system should aggregate and evaluate data, present-
ing the relevant data to inform the user’s decision mak-
ing process.
For this reason, unlike earlier work, Argudas does not
decide whether or not a gene is expressed. Instead it
aggregates and interprets information before summaris-
ing the material for the user.
Argumentation schemes
The argumentation schemes are derived from expert
knowledge of how to interpret and evaluate the informa-
tion in the EMAGE and GXD resources. The expert
used for this task was responsible for curating the infor-
mation in EMAGE, and thus interpreted and evaluated
the information in these resources on a daily basis.
Unfortunately, there is little published research on the
creation of argumentation schemes by a domain expert
with which to compare the current work. The available
literature on schemes often focuses on the dialogue and
natural language aspects. The work of Silva et. al. [21] is
interesting because it starts with already documented
“reasoning templates” (effectively diagrammatic argu-
mentation schemes) and asks a domain expert to use
those to explain his reasoning, customising them if
necessary, during case-based reasoning. The process of
customising the schemes provides a mechanism to help
the expert describe his knowledge. However, no such
pre-existing schemes exist for the current domain.
Shipman and Marshall [22] discuss the problems of
working with a number of knowledge formalisms,
including argumentation. Although their work does not
focus directly on the application of schemes, a number
of their ideas do transfer over, for example:
Tacit knowledge is knowledge users employ without
being conscious of its use [23]. Tacit knowledge
poses a particularly challenging problem for adding
formal structure and content to any system since, by
its very nature, people do not explicitly acknowledge
tacit knowledge.
The notion that experts are not aware of all their
own knowledge presents a massive impediment for all
knowledge-based approaches. Similar ideas can be
found in the work of Bliss [24], which suggests that
experts develop mental models of concepts and pro-
cesses that can be very hard for them to access. Such
knowledge, referred to as deep knowledge, is unarticu-
lated. Knowledge that has never been articulated can
be extremely difficult for the expert to recall [24-26].
The biological expert, used in this work, was being
asked to provide tacit knowledge, and struggled to do
so.
Degrees of confidence for argumentation schemes
In order for the argumentation engine to argue, it
requires not only a series of logic rules (derived from
the schemes) but additionally that each rule has an asso-
ciated confidence score. These scores, so-called degrees
of belief, should record the expert’s confidence, in each
rule, in such a way that rules with a high value produce
better arguments than rules with a low value. The argu-
mentation engine uses the scores to settle conflict,
decreeing that when two arguments oppose one another,
the argument with the higher value wins.
During the evaluation of the second prototype the bio-
logical expert disagreed with his own assignments,
which raises questions over the reliability of their cap-
ture. However, this is not the only plausible explanation,
Bliss [24] suggests that mental models naturally evolve
as the person gains experience and knowledge, or as a
result of the person consciously thinking about their
processes and knowledge. Consequently, the act of ask-
ing an expert to document their knowledge can change
that knowledge, and thus render the assigned confidence
value redundant.
A further issue to be aware of when dealing with
experts, is the reliability of the individuals themselves.
As Walton [27] notes, the users of expert opinion often
are not capable of judging the quality of that opinion
and thus simply apply it:
It is quite common for presumptions to be based on
expert opinion where the person who acts on the
presumption - not being an expert - is not in a posi-
tion to verify the proposition by basing it on hard
evidence within the field of expertise in question.
Walton [27] goes on to caution that such experts, or
authorities, may not prove to be reliable:
But even when they are nonfallacious, as used in a
dialogue, appeals to authority are generally weak,
tentative, presumptive, subjective, and testimony-
based arguments. They are inherently subject to cri-
tical questioning, or even rebuttal, on various
grounds - especially on grounds relating to the relia-
bility of the source cited.
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Walton’s opinion is backed by a number of scientific
studies, as Hansson [28] reports:
Experimental studies indicate that there are only a
few types of predictions that experts perform in a
well-calibrated manner. Thus, professional weather
forecasters and horse-race bookmakers make well-
calibrated probability estimates in their respective
fields of expertise [29,30]. In contrast, most other
types of prediction that have been studied are sub-
ject to substantial overconfidence. Physicians assign
too high probability values to the correctness of
their own diagnoses [31]. Geotechnical engineers
were overconfident in their estimates of the strength
of a clay foundation [32].
These quotes combine to illustrate the difficulty in
using expert opinion - often it is not correct, and the
user has no way of knowing what (s)he can trust. As
such, it is conceivable that the expert did not assign the
correct confidence values. Furthermore, the authors
were incapable of verifying the quality of the
assignments.
Argudas’ solution
The previous work demonstrates a need for an
improved set of schemes and confidence values. Two
significant barriers appear to exist: the difficulty in the
expert articulating his own knowledge, and the reliability
of an expert’s opinion. Instinctively, the solution to both
of these issues is the inclusion of further experts in the
process. Having a second expert allows ideas to be com-
municated and evaluated by people in different ways.
Thus helping to reduce both the subjectivity and the
workload on an individual expert making it easier for
them to generate the required output.
Regrettably, Argudas did not have the resources to
restart the full scheme generation process. Conse-
quently, as described later, Argudas employed two
experts to review the schemes and assign new confi-
dence values. These amended schemes and values are
used in Argudas’ first prototype (3rd overall).
Clearly having two experts means the possibility of
two different points of view. Hence, when they both
agree, the probability of the degree of confidence being
accurate increases. Disagreement is beneficial too,
because through it new insights are discovered. It seems
obvious that if the schemes had been produced by mul-
tiple experts the range and diversity of the schemes
would have been broader. Furthermore, if two experts
have to agree the natural language used to document
the schemes, the number of ambiguous phrases should
be reduced.
Yet working with multiple experts can cause a number
of difficulties. Expert biologists are often geographically
disparate. This in conjunction with their workload
means it may be difficult to bring the experts together.
Furthermore, there is an obvious requirement for a for-
mal resolution process to help dissect and settle differ-
ences of opinion. Finally, it must be acknowledged that
not all disagreements can be rectified, and that a
mechanism for incorporating differences of opinion
must exist. These issues point to the requirement for a
framework that enables biologists to work together in
order to generate the schemes. Lindgren [33] is develop-
ing such a framework for the use case of dementia care;
however, it is still at an early stage, and cannot be
employed here.
Extending Argudas for richer argumentation
Argudas aims to improve on previous work with the
integration of further resources - more resources means
extra information and potentially richer arguments.
Initially the microarray data contained in the ArrayEx-
press [34] resource was targeted. This highlights a num-
ber of integration issues that have yet to be resolved.
Firstly, the ArrayExpress resource does not use the
EMAP anatomy ontology. Secondly, accessing the data
held by ArrayExpress was difficult as they did not pro-
vide a direct programmatic access to their database.
Instead access was via a RESTFUL web service, which
provided limited functionality and did not allow access
to the data required by this work. Initially it was impos-
sible to ask for all the genes expressed in a healthy
mouse’s pancreas at stage 24 because ArrayExpress did
not compute multi-factor statistics. That is, they com-
puted which genes were expressed in the pancreas and
which genes were expressed in stage 24 separately and
there was no way of presenting the intersection at that
time. The team behind the resource were working on
improving this interface and claimed that such function-
ality would become available in the future; however, the
delay was problematic because of the time constraints
associated with Argudas. Finally, ArrayExpress had less
data for the developmental mouse than expected: only
three stages were covered. Comparing the costs and
benefits it was decided not to pursue this integration
further.
As work on ArrayExpress stopped an investigation of
the Allen Brain Atlas (ABA) [35] and Gene Expression
Nervous System Atlas (GENSAT) [36] began. Both of
these resources are databases of in situ experiments
focusing predominately on the adult mouse’s nervous
system, i.e. brain. The latter project makes available a
full database dump. The former supplies an extensive
range of RESTFUL interfaces that provide access to the
desired information.
However, bringing the data from these two new
resources into Argudas is problematic. Neither resource
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uses the EMAP anatomy - as these resources focus on
the brain they have a far finer granularity for the brain
structures than EMAP. Hence it is necessary to attempt
some form of mapping from their respective anatomies
to EMAP. Secondly, these resources use their own mea-
sures to describe the level of expression, GENSAT nat-
ural language terms and ABA floating point numbers,
which also must be mapped across to the corresponding
EMAGE/GXD terminology. EMAGE and GXD use very
similar labels, for example when a gene is not expressed
in a particular structure GXD describe the gene as
absent whereas EMAGE use the term not detected.
Mapping between the different anatomy ontologies
employed by the resources is based on a series of align-
ments produced by Jiménez-Lozano et al. [37]. As both
GENSAT and ABA have a finer granularity than EMAP,
mapping from those resources to EMAGE/GXD com-
monly results in a loss of precision.
The second task is straightforward for GENSAT as
their choice of labels is similar to EMAGE’s, and in turn
GXD’s. Whereas EMAGE has not detected, detected,
weak, moderate, and strong GENSAT has not done,
undetectable, weak signal, and moderate to strong signal.
Mapping EMAGE/GXD expression levels to ABA is a
more complex task. There are three different measures
of expression level published by ABA. Firstly there is
the raw experimental information, secondly there is the
average information (across all the experiments for a
particular gene and structure), and finally there is a
mathematical aggregation of the expression level and
expression density. For current purposes, the first class
of information is most suitable. Subsequently, the ABA
generated expression level mappings must be applied.
These mappings are a series of cut-offs that determine
whether the expression level is not expressed, weak,
moderate or strong. There are different limits for differ-
ent parts of the brain. In order for the limits to be
applied to the structures lower down in the anatomy
hierarchy, the limits need to be propagated through the
brain in a similar manner to the gene expression
information.
When this work has been done it is necessary to
determine what level of integration is appropriate for
these resources. At the most basic level it would be pos-
sible to merely report the results contained in ABA and
GENSAT. If either of these resources agreed with an
annotation from EMAGE/GXD, it would increase the
confidence in that annotation. Fully integrating ABA
and GENSAT would require the generation of schemes
for these resources, which is substantially more work
and would necessitate involvement from a resource
expert. In the case of ABA such an approach may not
be fruitful; ABA does not publish all the data it collects,
accordingly some of the attributes provided by an expert
may be hidden from the public, and thereby Argudas.
The restricted resources of Argudas meant that only the
former option was realistic.
Although an interested biologist may raise a number
of concerns regarding the anatomy and expression level
mappings described above, currently there is no better
way of aggregating data between the four resources of
interest.
Further issues identified during the development of
Argudas
The first Argudas prototype tests using the revised
schemes and confidence values. For the reasons dis-
cussed before, it removes the final conclusion and
instead presents a list of textual arguments. When this
initial system was demonstrated to a group of end users
they raised concerns over the number of arguments
shown and the style of their presentation. These topics
shall be explored in greater depth before a possible con-
clusion is presented.
Too many arguments
During Argudas’ development it became evident that
the number of arguments generated varies enormously.
For some queries there are no annotations and there-
fore no arguments. With other queries over ten anno-
tations are retrieved from EMAGE and GXD,
accordingly a large number of arguments are produced:
arguing for bmp4 - future brain in stage 15 generates
two hundred and fifteen arguments. Clearly, no biolo-
gist will read all the arguments, hence there can be no
guarantee that (s)he will read all the important infor-
mation. This realisation led to the conclusion that the
potential number of arguments is too high, and steps
were taken to reduce it.
Although all of the arguments are unique in terms of
their content (wording, and order of words) semantically
several arguments seem to duplicate one another. Iden-
tifying semantically equivalent arguments is not a minor
task. The definition of equivalent seems to depend on
the individual using the system and the biological task
they wish to perform.
There are a number of common interpretations and
actions that are not appropriate for certain biological
tasks, and which individual biologists may, in general,
reject. For example, the EMAP anatomy ontology is
defined using part-of relationships. Consequently, posi-
tive levels of expression are routinely propagated up the
ontology to higher level structures; for instance, if bmp4
is weakly expressed in the telencephalon, it is normally
correct to say that bmp4 is weakly expressed in the
future brain. Nevertheless, many biologists prefer direct
annotations over propagated ones, thus if a second
annotation suggests bmp4 is not detected in the future
brain, the second annotation would take precedence.
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Likewise, there is a similar problem with the granular-
ity of information desired. Finding two distinct annota-
tions with the same conclusion is a powerful argument
for trusting the conclusion. However, the granularity of
information desired affects the decision as to whether or
not the annotations are in agreement. Imagine there are
two annotations: one annotation suggests bmp4 is
strongly expressed in the future brain, and a second
annotation demonstrates bmp4 is weakly expressed in
the future brain. If the biologist is attempting to deter-
mine if the gene is expressed or not expressed, then
these annotations may be taken to agree. Yet, if the aim
is to determine the level of expression, these annotations
are conflicting.
The goal of reducing the number of possible argu-
ments is further hindered by a request for more positive
aspects to be highlighted. For instance, although an
argument is created when the probe (used to detect the
presence of an expressed gene) information is absent for
an experiment, no argument is created when it is
present.
In summary, Argudas’ users appear to wish for a
broader range of prospective arguments, and yet a smal-
ler number of realised arguments. Reconciling these
competing aims seemed improbable, until someone
remarked that the problem was not the volume of the
arguments but the amount of text to be read. It tran-
spired that a significant number of potential users
wanted to scan information rather than read it.
The notion of argument reconsidered
Previous work, and the initial version of Argudas, use
the ASPIC argumentation engine to generate and evalu-
ate arguments inside a virtual debate. These arguments
are presented to the user as a natural language para-
graph - this display mechanism is chosen as it is the
preference of the original expert. However, feedback
suggests this choice is subjective [15]. Furthermore, the
potential for a large number of arguments to be gener-
ated appears to imply that the original approach is sub-
optimal. There is a clear need to find an alternative
method for displaying arguments.
During internal discussions it was proposed that the
argumentation mechanism should be reconsidered.
This approach was based on the belief that users
wanted quick access to certain key attributes of the
annotation. Theoretically there is no need to employ
the argumentation engine to create and evaluate argu-
ments. Instead, the most important schemes (as identi-
fied by the scheme revision process), should be the
basis for a range of key attributes that describe the
annotation. The schemes indicate whether or not the
information stored in EMAGE/GXD for a particular
annotation should increase or decrease a user’s confi-
dence in that annotation. As such, Argudas should
extract information from the resources and present it,
with associated key highlights, to the user. It then
becomes the duty of the user to evaluate the
information.
In order to test this hypothesis two mock interfaces
were created and evaluated. There are three steps to
each interface. The first two steps are the same: select a
gene and/or structure of interest; report on the available
annotations and allow the user to ask for more informa-
tion if desired. Figure 2 shows both of these: initially the
query is bmp4 - future brain in all stages; the query
causes all combinations of the gene and structure to be
displayed in a table. The table presents all relevant
annotations, summarises what each annotation shows,
and provides a link to the resource’s web page for that
annotation.
In some situations the table in Figure 2 will be enough
to resolve a biologist’s question; i.e. it is clear that bmp4
is expressed in the future brain in stage 14. On the
occasions when the table is not helpful, or does not pro-
vide enough information, clicking the argue button pro-
vides a range of arguments.
In the first mock interface a number of textual argu-
ments are displayed - in a similar manner to Figure 1
part B. The second interface can be seen in Figure 3 -
the ‘arguments’ are now a list of key attributes such as
multiple annotations agree. Whether or not an attribute
should strengthen a user’s confidence in the annotation
is indicated with a tick or cross. The attributes are
divided into two layers - firstly by expression level, and
then by annotation. For each level of expression there
are three attributes that indicate how likely that level of
expression is. Asking for more information causes the
second layer of attributes to appear. This allows the
user to evaluate the annotations individually, and collec-
tively as a group that promotes a specific expression
level.
Argument presentation reconsidered
The mock interfaces, shown in Figures 2 and 3, were
explored with the help of two expert users. During this
small informal exercise (described later in the Methods
section), the test users were kept apart; however, they
reached identical conclusions:
1. the revised interface, using key attributes rather
than textual arguments, is an improvement;
2. a further improvement could be made by placing
the content of Figure 3 into a table.
Separately, the experts both had the idea contained in
Figure 4. Effectively, the important schemes become col-
umns, with individual annotations represented as rows.
Ticks indicate positive aspects that suggest the annota-
tion is more likely to be correct, with crosses having the
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opposite semantics. Blue dashes inform the user that a
piece of information is unavailable.
Enacting these recommendations has a major side
effect: there is no need to perform computational argu-
mentation. As such, there is no need for the argumenta-
tion engine. Instead the user now performs the
argumentation themselves using the aggregated and
curated information presented by Argudas.
This change helps address the issue of subjectivity,
because the user is now able to apply his/her own confi-
dence values and criteria to the decision making pro-
cess. Furthermore, because the user is able to build his/
her own arguments, Argudas becomes a more flexible
tool. For example, it is now possible to use Argudas to
decide where, and at what level, a gene is expressed.
Implementing these changes results in the second, and
current Argudas system (the user interface can be seen
in Figure 4). One addition to the advice offered by the
expert users is the inclusion of mouse-overs to present
extra information. Discrete dots underneath a tick/cross,
or column title, indicate that more information is avail-
able if the user hovers his/her mouse over the dots. For
example, hovering the mouse over the dots in the cell
for ‘strong - multiple annotations agree’ (Figure 4, top
table) reveals the experiment(s) that suggest the gene is
strongly expressed.
The evaluation of this system, described later, demon-
strates that the changes are both appropriate and effec-
tive because they allow users to quickly scan the
important information.
Figure 2 Argudas prototype interface; part one. Mock-up of the user interface: simple form allows user to search for gene and/or anatomical
structure in relation to a particular Theiler Stage. Doing so produces a table summarising the relevant annotations found in EMAGE and GXD.
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http://www.biomedcentral.com/1471-2105/13/S1/S8
Page 9 of 15
Future work
This work set out to model expert knowledge and use it
to reason with information sources available through
the Internet. In the current use case, this appears to be
beyond the scope of what a typical end user wishes.
However, the current use case is relatively constrained,
and thus contained: it focuses on one kind of gene
expression information for one model organism. Extend-
ing the use case to include different types of biological
information, for example gene regulatory networks,
Figure 3 Argudas prototype interface; part two. Mock-up of the user interface: potential display mechanism for arguments. Clicking on an
argue button from Figure 2 produces an output where different attributes are assigned a positive (tick) or negative (cross) indicator. Positive
indicators demonstrate the annotation is more likely to be correct.
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Figure 4 Argudas final interface; presentation of arguments. Implemented display mechanism for arguments. Important data attributes are
columns in the tables. The two tables in this Figure are beneath a table similar to that shown in Figure 2. The top table, in this figure, features
strength of expression as the rows. A tick indicates a positive reason to trust the level of expression, a cross provides a reason to doubt the level.
The three dots underneath a tick or cross indicate that more information is available as a mouse-over, e.g., the tick for ‘strong - multiple
annotations agree’ presents the experiments with matching annotations. The final table has one row dedicated to each annotation. The strength
of expression is colour co-ordinated with the first table. The key is the same, with the addition of blue dashes reporting that data is unavailable.
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makes the use case considerably more complex. As the
intricacy of the biological investigation increases, the
need for user support likewise increases. Argumentation
is one possible support mechanism.
Another avenue for future work relates to CUBIST,
Combing and Uniting Business Intelligence with Seman-
tic Technologies, an EU FP7 project that aims to com-
bine the essential features of Semantic Technologies,
Business Intelligence, and Visual Analytics. Data from
both unstructured and structured sources will be feder-
ated within a Business Intelligence enabled triplet store,
before visual analysis techniques such as Formal Con-
cept Analysis [38] are applied. One of the project’s three
use cases involves the gene expression data described in
this paper. Although it is early in the life of the CUBIST
project, a semantic Extract Transform Load [39] process
that includes computational argumentation may be envi-
sioned. The inclusion of argumentation may provide an
intelligent transformation of data, and a user-friendly
explanation of the transformation.
Conclusions
This paper describes the rationale for generating an
argumentation tool (Argudas) to tackle the inconsistency
and incompleteness found in in situ hybridisation gene
expression resources for the developmental mouse.
Furthermore, it discusses the development of Argudas
highlighting some of the critical problems still
outstanding.
Although the paradigm of argumentation initially
seemed promising for this use case, it is clear that in
this case, biologists are not interested in the full poten-
tial of argumentation. To them the ability to generate
and automatically evaluate many arguments is not of
primary interest. Nor is the presentation of a conclusion
- they wish to make that decision. As such there is no
place in Argudas for the version of computational argu-
mentation carried out in previous work. Instead the
concept of an argument, as a reason to believe some-
thing, can be used to present key attributes that provide
a good indication of whether or not an annotation can
be trusted, and thus whether or not a gene is expressed.
Computational argumentation may not be wholly
appropriate for the current use case, yet that does not
mean that the technology cannot be applied to other
domains within the Life Sciences. The current use case
is restricted in terms of its complexity. For more elabo-
rate situations, in which data from multiple fields is
aggregated for knowledge generation, the user support
provided by argumentation may be more valuable.
For argumentation to be successfully applied within
the biological domain, this work shows that two strands
of activity are important. Starting within the biological
domain, it is clear that integration of resources is
essential. To tackle the incompleteness of a single biolo-
gical resource it is necessary to aggregate data from
other sources. Argudas tried to expand beyond its initial
online sources; yet, doing so introduced a number of
challenges. All the resources featured in this paper are
essentially conducting the same task for the same type
of information; however, the resources use different
anatomy ontologies, terminologies and methods.
Accordingly, integrating data is not a straightforward
task.
The issues faced when integrating data across sources
are not unique to in situ gene expression for the devel-
opmental mouse. They are applicable to all domains
which involve experimentation on model organisms.
Currently, there is no adequate solution to these diffi-
culties and users have to accept some limitations.
The second requirement, for argumentation to be suc-
cessfully utilised, is an improvement in the quality and
availability of argumentation methods and tools. The
argumentation community must tackle the open ques-
tion of how best to present arguments and argumenta-
tion, and produce a collaborative mechanism to enable
biologists to model and record domain knowledge them-
selves. Finally, there is a requisite for the community to
have their work freely available through the creation of
open, reliable, and scalable argumentation toolkits. Cur-
rently, there are few such resources available.
Even with these issues resolved, the effectiveness of
computational argumentation in biology hinges on the
quality of the domain modelling. Regardless of the appli-
cation domain, the effort required to model domain
information is significant. This cost presents a substan-
tial barrier to the successful adoption of computational
argumentation within biology, and raises questions over
whether argumentation can reach its full potential
within this domain. Yet the same is true for the Seman-
tic Web, and as James Hendler and others [40] have sta-
ted - a little semantics goes a long way.
Whilst it must be acknowledged that the tools to sup-
port argumentation are currently too immature for real
world use, and the principles behind those tools require
refinement, it seems clear that the concept of argumen-
tation has real potential within the life sciences.
Methods
In this section a number of activities relating to the
work described previously will be documented. The pro-
cedure for accessing and revising the argumentation
schemes and their confidence values will be tackled first.
Subsequently the informal evaluation of the first Argu-
das prototype will be recounted, before the evaluation of
the second prototype is considered. The implementation
of Argudas will not be discussed as that is largely a soft-
ware engineering exercise.
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Revising the argumentation schemes and confidence
assignments with multiple experts
As discussed above, when the previous work was evalu-
ated [15] a number of evaluation subjects disagreed with
the expert’s schemes and his assignment of degrees of
confidence to those schemes. Argudas did not have the
resources to create a new set of schemes as this was a
sizeable task; nevertheless, it was possible to review the
schemes and their confidence values. To this end, two
experts were asked to appraise the list of previously gen-
erated schemes. Separately, each expert awarded each
scheme a score:
0 disagree with the scheme, i.e. reject;
? don’t know - scheme is very weak and is on the bor-
der between being rejected and being classified as a
weak scheme;
1 weak scheme, i.e. low confidence;
2 moderate scheme, i.e. medium confidence;
3 good scheme, i.e. high confidence.
In total, the two experts were asked to assign a score
to sixty-eight schemes. The experts completely agreed
upon - that is they gave exactly the same score to - six-
teen schemes. A further thirty-three schemes were
assigned a similar score. The notion of similar being
defined as an adjacent score, i.e. if one expert assigned
2, then either a 1 or a 3 would be classified as similar. If
the two experts assigned scores that were neither adja-
cent nor exact matches, they were deemed to disagree -
this happened with nineteen schemes.
In conclusion, the experts broadly agreed on 72% of
the schemes. This left 28% of the schemes for which the
disagreement was marked. Regrettably, one of the
experts emigrated shortly after this exercise was com-
pleted and was no longer available to assist in the devel-
opment of Argudas. Therefore this disagreement was
never resolved, nor was its root cause investigated.
Potentially the source of the disagreement was very
interesting, as it was not clear whether the conflict
between the experts was caused by a genuine difference
of opinion or a difference of interpretation. As the
schemes were written in natural language, the latter is a
distinct possibility.
Reconsidering the presentation of arguments
Originally arguments were presented entirely in natural
language, e.g. Figure 1 part B. An alternative was to
summarise the information by displaying only key attri-
butes, e.g. Figure 3. This small informal exercise
attempted to decide which mechanism was more appro-
priate for the potential users.
The two presentation styles of argument were evalu-
ated with the assistance of two expert users from the
Medical Research Council’s Human Genetic Unit [41].
One expert had participated in the previous revision of
argumentation schemes and confidence values. The sec-
ond expert had attended a presentation on Argudas, but
had not previously had a role in Argudas’ development.
The expert evaluations were undertaken independently
with no discussion between the experts prior to the
evaluation.
Each expert user was presented with a description of
the planned evaluation, then a structured walkthrough
was conducted. Using a protocol, the user was guided
through each interface using the same search example:
bmp4 - future brain - stage 15. They were asked to raise
any issues or aspects they liked or disliked while under-
taking the interface evaluations. The experts were then
asked to score the interfaces out of ten in terms of their
usability. Ultimately, a limited set of questions was
asked to determine the user’s opinions on the require-
ments for refining aspects of the interface and argument
presentations.
In particular, one question directly asked which style
of presentation the subject preferred. A second question
asked how their favoured approach could be improved
further. As discussed above, the users provided very
similar answers, with a clear preference for displaying
only key attributes. Additionally, both test subjects prof-
fered the idea of using tabulation to improve the presen-
tation of the attributes.
Evaluation of second Argudas implementation
An evaluation of the new interface and latest version of
Argudas, represented by Figure 4, was undertaken with
eight users (consisting of biologists, bioinformaticians,
and computational biologists) working at the Medical
Research Council’s Human Genetics Unit. Work pres-
sures necessitated the restriction of each evaluation ses-
sion to twenty minutes.
The evaluation comprised a structured walkthrough
with the user being guided through a scenario of a typi-
cal Argudas query. This was followed by a usability eva-
luation questionnaire and a number of open-ended
questions to gather the user’s opinions on the presenta-
tion of results. Due to the small number of users, results
were largely qualitative rather than quantitative.
Users were asked to rate their opinion of a number of
aspects of the Argudas system using a five point scale.
Considering the response time of the system: seven
users rated it as “excellent” and one as “good”. Focusing
on the appearance of Argudas: one user described it as
“excellent” and seven as “good”.
The user ratings for how easy the three results tables
were to understand favoured “easy” and neutral, with
only two users finding the second and third results
tables (e.g. Figure 4) “difficult” to understand.
Whilst conducting the evaluation, the observer noted
that five of the users appeared to not see the key
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explaining the tables, suggesting that the key should be
placed in a position on the page that makes it more
prominent.
Failure to spot the key meant that the same users did
not read the explanation of the mouse-overs that it con-
tained. This was believed to be one contributing factor
to the apparent inability of several users to discover the
mouse-overs. Another relevant factor may be the delib-
erately discrete nature of the underlining used to indi-
cate the presence of a mouse-over. Attempts to ensure
the underlining did not intrude too significantly, appear
to have made the visual clue too difficult to see.
A number of general conclusions were drawn from
user comments made during the evaluation. For exam-
ple, the idea of triggering help information by mouse-
over. Additionally, several users felt the results tables
were too big, with the information too widely spaced.
These users recommended a reduction in white space
and cell size. When a user asks for more information
from the top results table (e.g. Figure 2), the top table is
hidden to allow more space for the presentation of the
two tables from Figure 4. To see the first table again,
the user must click on a hyper-link ("Show/hide gene
expression results” in Figure 2). It transpires that this
hyperlink should be more visible.
Overall, the conclusion drawn from the evaluation is
that the evolution of the interface to a tabular display
has achieved the desired aim of making the results
easier to “eyeball”. Accordingly, user satisfaction with
the tables is largely positive. However, the mechanisms
that provide the user with extra information about, and
context for, the results need to be improved.
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